Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.21.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash flows from operating activities:    
Net loss $ (1,884,019) $ (1,090,877)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock compensation expense (non-cash) 368,232 338,497
Changes in operating assets and liabilities, net    
Other current assets (51,879) (42,084)
Accounts payable, accrued expenses and other current liabilities (370,394) (331,106)
Net cash used in operating activities (1,938,060) (1,125,570)
Cash flows from financing activities:    
Cash proceeds from the sales of common stock under a Capital on DemandTM Sales Agreement with JonesTrading Institutional Services LLC, net of commissions, fees and offering costs of $338,153 and $34,384 for the three months ended March 31, 2021 and March 31, 2020, respectively 10,925,312 508,044
Taxes paid related to net share settlement of vested restricted stock units (21,500) 0
Cash proceeds from the issuance of stock upon exercise of stock options 17,478 0
Net cash provided by financing activities 10,921,290 508,044
Effect of exchange rates 2,774 (4,041)
Net increase (decrease) in cash and cash equivalents 8,986,004 (621,567)
Cash and cash equivalents at beginning of period 16,737,109 13,213,929
Cash and cash equivalents at end of period $ 25,723,113 $ 12,592,362